Dermatology · Birmingham, AL
NPI
1043572191
Since 2012
Specialty
Dermatology
Code 207N00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1717 6th Ave S
Birmingham, AL, 35233
Phone (800) 822-8816
Groups this clinician bills Medicare through
Medicare paid, 2024
$17K
643 services
Medicare patients, 2024
168
Average age 68
Drug cost, 2024
$1.4M
546 prescriptions
Company payments, 2025
$88K
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tiffany Mayo was code 17003 (destruction skin lesion), 220 times for 35 patients. In total Tiffany Mayo billed 643 services in 20 codes, and Medicare paid $17K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-06-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Facility | 220 | 35 | $1.33 | $293 |
| 99214 Office E&M - Established | Facility | 116 | 93 | $62.09 | $7,202 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 69 | 59 | $11.18 | $772 |
| 17000 Destruction Skin Lesion | Facility | 46 | 39 | $30.86 | $1,419 |
| 99213 Office E&M - Established | Facility | 43 | 42 | $42.44 | $1,825 |
| 99204 Office E&M - New | Facility | 23 | 23 | $88.50 | $2,036 |
| 17110 Destruction Skin Lesion | Facility | 21 | 19 | $43.76 | $919 |
| 11102 Skin Biopsy | Facility | 21 | 20 | $19.34 | $406 |
| 11900 Skin | Facility | 18 | 16 | $18.44 | $332 |
By year: 2022 $18K for 466 services; 2023 $18K for 523 services; 2024 $17K for 643 services.
Medicare prescription drug claims, 2024
In 2024, the drug Tiffany Mayo prescribed most often to Medicare patients was Ketoconazole, with 61 prescriptions and refills. In total Tiffany Mayo wrote 546 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 61 | 69 | 16 | $1,615 |
| Clindamycin Phosphate Generic | 38 | 40 | 12 | $1,569 |
| Triamcinolone Acetonide Generic | 31 | 37 | 26 | $507 |
| Dupixent Pen Dupilumab | 30 | 30 | Under 11 | $107K |
| Minoxidil Generic | 27 | 50 | Under 11 | $183 |
| Remicade Infliximab | 21 | 23 | Under 11 | $449K |
| Sodium Chloride 0.9 % Sodium Chloride | 20 | 20 | Under 11 | $140 |
| Betamethasone Dipropionate Generic | 19 | 20 | Under 11 | $750 |
| Clobetasol Propionate Generic | 16 | 18 | Under 11 | $816 |
| Opzelura Ruxolitinib Phosphate | 16 | 16 | Under 11 | $31K |
| Diphenhydramine Hcl Generic | 14 | 14 | Under 11 | $62.61 |
| Dupixent Syringe Dupilumab | 14 | 14 | Under 11 | $50K |
| Metronidazole Generic | 13 | 14 | Under 11 | $1,354 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 13 | 13 | Under 11 | $1,060 |
| Halobetasol Propionate Generic | 13 | 13 | Under 11 | $1,389 |
Brand drugs: 182 claims; generic drugs: 364 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tiffany Mayo $88K ($85K in general payments such as food, travel and fees and $2,832 for research) from 16 companies. The largest payer was Pfizer Inc. with $26K.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 13 | $26K |
| Regeneron Pharmaceuticals, Inc. REGN | 14 | $14K |
| UCB, Inc. UCB.BR | 15 | $13K |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 14 | $11K |
| Eli Lilly and Company LLY | 2 | $7,500 |
| Merck Sharp & Dohme LLC MRK | 1 | $5,760 |
| Arcutis Biotherapeutics, Inc. ARQT | 2 | $3,750 |
| LEO Pharma Inc. | 5 | $3,262 |
| Abbvie Inc. ABBV | 4 | $2,600 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $865 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.